The U.S. online prescription drug platform had planned to sell 34.6 million shares in its IPO at a target range of $24 and $28 per share.
GoodRx did not immediately respond to a request for comment.
GoodRx sells shares in IPO above target range – source
4 years ago
No Comments
Related Posts
Pro-Trump rioters could face up to 20 years in prison
January 7, 2021
Indeed’s CMO on why every company should view marketing as a growth center, not a cost center
August 30, 2022
Fortune poll: 63% of Americans worry they won’t be able to pay their bills during the coronavirus crisis
March 19, 2020
I wasn’t ready to watch Jacob Blake get shot in the back. Social media didn’t care
August 25, 2020
Wall Street dreams of working for Jamie Dimon
July 24, 2023
The U.K.’s coronavirus plan focuses on delaying the peak of the outbreak
March 12, 2020
About The Author
